Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 55 | 100 | 3,045 | 0 | 9,000 |
| Gross Profit | 55 | 100 | 3,045 | N/A | 9,000 |
| Operating Expenses | 2,967 | 3,312 | 2,638 | 1,588 | 9,779 |
| Operating Income | -2,912 | -3,212 | 407 | -1,588 | -779 |
| Interest Expense | -75 | -53 | -37 | 646 | 5,507 |
| Other Income | -2 | -9 | -5 | 12,997 | 0 |
| Pre-tax Income | -2,839 | -3,168 | 439 | 10,763 | -6,286 |
| Net Income Continuous | -2,839 | -3,168 | 439 | 10,763 | -6,286 |
| Net Income | $-2,839 | $-3,168 | $439 | $10,763 | $-6,286 |
| EPS Basic Total Ops | -0.94 | -1.33 | 2.70 | 5.80 | -3.94 |
| EPS Basic Continuous Ops | -0.94 | -1.33 | 2.65 | 5.85 | -3.94 |
| EPS Diluted Total Ops | -0.94 | -1.33 | 2.70 | 5.80 | -3.94 |
| EPS Diluted Continuous Ops | -0.94 | -1.33 | 2.67 | 5.84 | -3.94 |
| EPS Diluted Before Non-Recurring Items | -0.94 | -1.33 | 0.20 | 5.80 | -1.20 |
| EBITDA(a) | $-2,908 | $-3,204 | $414 | $-911 | $4,762 |